Clinical Trials Browser

Phase 1 × Interventional × Metastatic Castrate Resistant Prostate Cancer (mCRPC) × Clear all

NCT06943495 2025-09-09

PRODIGY-2

Phase 1 Recruiting

Metastatic Castrate Resistant Prostate Cancer (mCRPC)

NCT02826772 2020-03-17

Safety, Tolerability, and PK of GT0918 (Proxalutamide) in Subjects With Metastatic Castrate Prostate Cancer

Phase 1 Completed

Metastatic Castrate Resistant Prostate Cancer (mCRPC)